Medication reference
Ceftobiprole medocaril
Monograph awaiting updateThis monograph will be updated in the future.
No original site article was mapped to this record. The available historical structured fields and official-source links are retained.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- ceftobiprole-medocaril
Source ID
H51-01F3C0CF05FEBBB206C01911 - Generic name
- Ceftobiprole medocaril
Source ID
H51-0057A8DAE863AAF3AFDC0443 - Class
- Antibacterial
Source ID
H51-75F42E7A7A2A16C90CC66E23 - Subclass
- Advanced-generation cephalosporin
Source ID
H51-3795026EC17BF85F30A5B7B2 - Primary uses
- Staphylococcus aureus bloodstream infection in adults
Source ID
H51-261E585A2C8950F1F66F6183 - Acute bacterial skin and skin structure infection
Source ID
H51-A16609A67673B058A6184383 - Community-acquired bacterial pneumonia in adults
Source ID
H51-0201A5EA91D546DA1CBB8596
- Staphylococcus aureus bloodstream infection in adults
- Mechanism
- Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis.
Source ID
H51-1DA2686D2082C88A0A374799 - Mechanism level
- class_level
Source ID
H51-166CA2A06AC88568F51FB47C - Basic dosing orientation
- Adult | Existing preparation record; use current package insert for indication-specific selection | 667 mg ceftobiprole medocaril per dose for many adult indications | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric | Existing preparation record; use current package insert for indication-specific selection | Weight- and age-based label dose | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion
Source ID
H51-EB2E2A4B3F2E1E1769AD6D83 - Administration orientation
- Infuse over 2 hours
Source ID
H51-4499BE0F5C6D4887891FFC4E - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
Source ID
H51-DA9604825D7A44B5E57A4D0F - Key safety orientation
- Serious beta-lactam hypersensitivity.
Source ID
H51-5BD6453F3C05DF03ACDAC747 - Renal adjustment is required.
Source ID
H51-A35B2167C83F48051D82B1C8 - Verify indication because approval differs by age group.
Source ID
H51-D39B14C24B719E18A3631CB2
- Serious beta-lactam hypersensitivity.
- Coverage path
- structured_local_snapshot
Source ID
H51-DC66FE5A1091EC722C5870B0 - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-F22F18375BB7F964008918C1 - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2bd685df-7dc6-78a6-e063-6294a90a580b (opens in a new tab)
Source ID
H51-5A9E47AEB294FF0BD7CEFCCC - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-AE006DA622F0CAE94C011889 - Search text
- Ceftobiprole medocaril Antibacterial Advanced-generation cephalosporin Staphylococcus aureus bloodstream infection in adults Acute bacterial skin and skin structure infection Community-acquired bacterial pneumonia in adults Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis. Adult | Existing preparation record; use current package insert for indication-specific selection | 667 mg ceftobiprole medocaril per dose for many adult indications | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric | Existing preparation record; use current package insert for indication-specific selection | Weight- and age-based label dose | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion Infuse over 2 hours Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method. Serious beta-lactam hypersensitivity. Renal adjustment is required. Verify indication because approval differs by age group. Structured GlobalRPh route snapshot ZEVTERA ZEVTERA (ceftobiprole medocaril sodium) injection, powder, for solution DailyMed label snapshot dosage administration dosage forms strengths mechanism
Source ID
H51-2880EF1358E4F08C5E2EB38A - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ceftobiprole+medocaril (opens in a new tab)
Source ID
H51-47D9FFD5F4C64766EE4C6790 - Official access mode
- direct_label
Source ID
H51-C578B421178F56700A58DFEA - Official access url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2bd685df-7dc6-78a6-e063-6294a90a580b (opens in a new tab)
Source ID
H51-B09197A7AAA909628A09431A - Official search query
- Ceftobiprole medocaril
Source ID
H51-DC2DC674535736508C13B1E9 - Official access reason
- Very-high-confidence exact IV product label selected during the v5.1 build-time review. Open the current full DailyMed monograph and verify the stocked product before use.
Source ID
H51-F2D6312CF1B3FC85B493ABBB - Label snapshot available
- true
Source ID
H51-DEACE64129625B5D6C83C520 - Label snapshot setid
- 2bd685df-7dc6-78a6-e063-6294a90a580b
Source ID
H51-08B7848A6E2AA9454615DAE5
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- A retrieved source document is available; clinical reconciliation and a second-source claim map remain incomplete
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- adjustment_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- class_level
- Provenance classification
- historical_class_level
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Source kind
- label_snapshot
- Local pointer
- /mechanism_summary
- Original level
- class_level
- Provenance classification
- historical_class_level
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
No separate structured rows were bundled for IV push, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-F73C5D34E9924BD51626DA08Source IDH51-5C34F05F787E373A2923DC0F | 667 mg ceftobiprole medocaril per dose for many adult indicationsSource IDH51-C1B78F5659DAF5C4A9A21AFA | Reconstitute vial with the label-specified volume and diluent; gently invert or swirl.Source IDH51-CA25DEC0F949CD5D9557C3ED | Label-compatible NS or D5W solutionSource IDH51-FFEB414E8FC3527DB98B75F0 | Common final bag volume per label and patient fluid needsSource IDH51-2BED59DD26A55638328767BF | Final concentration approximately 2.67 mg/mL in the standard label preparationSource IDH51-7221180C832E7FF74F848596 | Infuse over 2 hoursSource IDH51-08DBC80EB5E9DB2BA0FFB5FB | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-D35566752517C63CE603DB72 | Dose interval and dose change with renal function; pediatric preparation is weight based.Source IDH51-EB14A3B18E102EDD165098E1 |
Source IDH51-73A72754AEF8545F68DA05EDSource IDH51-23CACB7E9F042A42C3D710D3 | Weight- and age-based label doseSource IDH51-1FC52BB40B15DE22120DCBAD | Reconstitute per product labeling.Source IDH51-C8FE1E92C9CDC81BAAD988FB | Label-compatible fluidSource IDH51-835745D4C4568F3D4B04367D | Weight-appropriate volumeSource IDH51-F0032F8738F0BCE1EFAF453A | Within label concentration rangeSource IDH51-2729AF6583BCAA05EC515BA5 | Infuse over 2 hoursSource IDH51-803E737C37192BC0070011E2 | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-B1446D19256EF92124AB2C20 |
Historical DailyMed label snapshot
Recovered v5.1 source content; historical, awaiting current review.
- Id
- ceftobiprole-medocaril
Source ID
H51-5F85653B4E257A1B2DD27720 - Catalog name
- Ceftobiprole medocaril
Source ID
H51-6ED3D9FEC913DE760F93F0D0 - Selection status
- accepted_high_confidence
Source ID
H51-BD6C7E4FC650D044829B3396 - Confidence
- very_high
Source ID
H51-DE55FBF3EA552B081F099EBF - Match path
- search_to_exact_label
Source ID
H51-792856CC211DA2931D646534 - Brand name
- ZEVTERA
Source ID
H51-134BEB7B9F5AC6B5587957C0 - Label title
- ZEVTERA (ceftobiprole medocaril sodium) injection, powder, for solution
Source ID
H51-6C6355582CB3F35B9977886B - Setid
- 2bd685df-7dc6-78a6-e063-6294a90a580b
Source ID
H51-6C73000E7739A3EEFA932BAF - Route
- Intermittent intravenous infusion
Source ID
H51-C775A84381F91BB79CAF7A45 - Dosage form
- Lyophilized powder for reconstitution and dilution
Source ID
H51-90498D46C92B15D6E43254AF - Dosage administration summary
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)
- For adults, the labeled dose is 667 mg every 8 hours for ABSSSI or CABP. For Staphylococcus aureus bacteremia, use 667 mg every 6 hours on days 1 through 8 and every 8 hours from day 9.
Source ID
H51-50AC60D30C494E5BEA142676 - Administer each prepared adult infusion over 2 hours at a final concentration of 2.67 mg/mL.
Source ID
H51-5C36A9C692AD503309A030B3 - Pediatric CABP dosing is age- and weight-based. Adult and pediatric renal adjustments, hemodialysis timing, and augmented-renal-clearance dosing require the current label tables.
Source ID
H51-25151CE223B085D58FF4F143
- For adults, the labeled dose is 667 mg every 8 hours for ABSSSI or CABP. For Staphylococcus aureus bacteremia, use 667 mg every 6 hours on days 1 through 8 and every 8 hours from day 9.
- Dosage forms strengths
- 667 mg ceftobiprole medocaril sodium, equivalent to 500 mg ceftobiprole, in a single-dose vial
Source ID
H51-5653D5E7025DDD368CF0979B
- 667 mg ceftobiprole medocaril sodium, equivalent to 500 mg ceftobiprole, in a single-dose vial
- Mechanism summary
- Ceftobiprole binds bacterial penicillin-binding proteins, including PBP2a, and inhibits cell-wall synthesis.
Source ID
H51-9F17060546A999E999EBF5D2 - Scope note
- Selected ZEVTERA label. Indication, age, renal function, and treatment day can change the interval.
Source ID
H51-E73199DA956ED8901516C589 - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2bd685df-7dc6-78a6-e063-6294a90a580b (opens in a new tab)
Source ID
H51-4FB7AD480219C639ACD931FC - Reviewed on
- 2026-08-31
Source ID
H51-037097B45B9C1D9783DA947B - Mechanism source
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
Source ID
H51-AB0F69B1C9128768C88DB70F - Source sections
- Dosage and Administration
Source ID
H51-2B34588C77F41588D48F6590 - Dosage Forms and Strengths
Source ID
H51-E60134564B2C11C87B0FE630 - Clinical Pharmacology or Microbiology as applicable
Source ID
H51-68F74BD79057961CC070AF51
- Dosage and Administration
- Retrieval method
- Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
Source ID
H51-15317FC5AE29E04D79838BC1 - Label status
- current
Source ID
H51-4F32BCCBDD563B086668481C - Disclaimer
- Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
Source ID
H51-11C7F31A1BD1345466F4D333
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
Separate renal reference: Open Renal Dosing Master (opens in a new tab)| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-4741CC01B0633CFD9811C258Source IDH51-543E5557B927C3D8ED2CB1E5 | AdultSource IDH51-8C50BB29EFFF2BCF632AAB45 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-49AFB510C07A2717538E97B8 | 667 mg ceftobiprole medocaril per dose for many adult indicationsSource IDH51-30EE129B97ABA875969059A9 | Not normalized in the preparation recordSource IDH51-2F9047706CACF24DAB7F3C76 | See current package insert and professional guidanceSource IDH51-33F319025E9B021988662454 | Infuse over 2 hoursSource IDH51-10AA0C33BEE187641CC2FF7A | Existing GlobalRPh structured preparation snapshotSource IDH51-B2097418E1265B7E8F54D1A1 | Dose interval and dose change with renal function; pediatric preparation is weight based.Source IDH51-66BC338F4F9CABAA94B49167 |
Source IDH51-E360FFB8018AD16808ACEBF8Source IDH51-CB7A8776594B700557F690D0 | PediatricSource IDH51-14981E78EC164497A0851A68 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-E1CD2B86514FA39DD7CD9BB9 | Weight- and age-based label doseSource IDH51-8E1B50425B8D3365C7FFADC8 | Not normalized in the preparation recordSource IDH51-8C74CD2DDE7722C05CDBC6A5 | See current package insert and professional guidanceSource IDH51-F1F3E1A25595A2888F6305F0 | Infuse over 2 hoursSource IDH51-71E28BF8CF41B155375A16B4 | Existing GlobalRPh structured preparation snapshotSource IDH51-C875FC97D9BA462116A30019 |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- adjustment_required
Source ID
H51-D5C3D0402385F443294C79D9 - Summary
- Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
Source ID
H51-6B3DE17D1900BC826036077E - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-17D32C85A9D16FB728E41AF9
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Staphylococcus aureus bloodstream infection in adults
Source ID
H51-20B7693A62219DE93E0D97D1 - Acute bacterial skin and skin structure infection
Source ID
H51-725EEA20C89B5D403C902167 - Community-acquired bacterial pneumonia in adults
Source ID
H51-E79085E3071A38C94132F126
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Serious beta-lactam hypersensitivity.
Source ID
H51-AC31CF41B01E6A1DD18F9F64 - Renal adjustment is required.
Source ID
H51-BA4F7526AF6E019E33CBF792 - Verify indication because approval differs by age group.
Source ID
H51-5B09D964D03E47A6DE1662BC
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal function
Source ID
H51-DBD05811B7324B0967563D16 - Clinical response and cultures
Source ID
H51-E0625787077650218012248A - CBC and hepatic tests during prolonged therapy
Source ID
H51-E5CB29908CA65DF15B45CFC4
Historical supplemental professional sources
Recovered v5.1 source content; historical, awaiting current review.
| Label | Url | Kind |
|---|---|---|
Source IDH51-1B5FA04CE2DE068DC9604476Source IDH51-84F5A65F07379C3187F002D1 | https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)Source IDH51-DFCA8974405CBE8255FD48E0 | Professional institutional guidanceSource IDH51-A3FFB9B3CB82CB314E9CDB49 |
Source IDH51-E25D134A9E120D4B740D7ECASource IDH51-DDEA728E01EDD38C6446CF0F | https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)Source IDH51-FF4F6437D8BB65D364652563 | Professional institutional guidanceSource IDH51-5352DC9DB5413A53DD73D7BE |
Source IDH51-EB1EC3F8D2146C0035E1B3D6Source IDH51-6007B6A793378888E5DD341D | https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-1DDE28E93202ED95C7972583 | Professional institutional guidanceSource IDH51-45FAD15AB4723E4EE011A1CF |
Source IDH51-31E8901664B4A1885B44B962Source IDH51-40E51E0E2995B679B7C8AD21 | https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-C4FC0D20E8CB32D162767E55 | Professional institutional guidanceSource IDH51-1F3D87B9464837157180DA4F |
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
ceftobiprole-medocarilSource ID
H51-76293988DDA72411660C9A9AGeneric name
Ceftobiprole medocarilSource ID
H51-FD326E325D5766A22AA1EC04Brand names
- Zevtera
Source ID
H51-29AF9CBB14B4993B137B53F0
Aliases
- ceftobiprole
Source ID
H51-FB6F8C22BA4CD8334AB9AB76
Class
AntibacterialSource ID
H51-AB9181AF390758B8828DBEEBSubclass
Advanced-generation cephalosporinSource ID
H51-5023B05747EE59F4E1006D4BSummary
Cephalosporin prodrug approved for selected adult bacteremia and pneumonia indications and pediatric skin infection, with a two-hour infusion.Source ID
H51-8E3A43F92D0D666A40010782Populations
- Adult
Source ID
H51-9D82E2185B8F2DDD0D298047 - Pediatric
Source ID
H51-C3893BF4768749DADF9FA76D
Evidence tier
Current-label candidate - verify exact productSource ID
H51-39229D5BF484FA66256B9A1EHigh alert
falseSource ID
H51-537F94AEA858DF502FF5FDEEHazardous
falseSource ID
H51-C7B21AC61A18D0F0F77B5A57Status
ActiveSource ID
H51-323D5537B743FC46A9495D64Reviewed
2026-08-29Source ID
H51-E6F1928503277F901A483874Version added
1.2Source ID
H51-5241062DBAA7F48716F3A999Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-911CDE96AFE95E959A4D9E78Source IDH51-EC7492E58AD27AE5238116B5 | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zevtera+ceftobiprole (opens in a new tab)Source IDH51-E3ACF4E6C2750BF9B7FC5241 | PrimarySource IDH51-24C949B969653A7974EDBD0D |
Source IDH51-4DB5315A41595FE7F1572AD1Source IDH51-A9D32C1B22BEC88207771F19 | legacy:autoSource IDH51-36D4629FDAD74227C9CD04F6 | LegacySource IDH51-53B4A3560A3A2555EEB37CF6 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-99974F269D0C3F19AFCB9B42 - Audited on
- 2026-08-30
Source ID
H51-AD313936CD1E1EAC6D706298 - Level
- amber
Source ID
H51-D5FF272FC05073F2A6B9E25A - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-D281DBCD09E3EA01ACA46732 - Exact current label candidate
- false
Source ID
H51-3F59BB5A5B4A6E166576D619 - Numeric support ratio
- 0
Source ID
H51-0C5C1711A4B6A7EDE6FED90E - Reference url count
- 5
Source ID
H51-DE4D7C5DE0E6ABDB849C0049 - Broken reference count
- 0
Source ID
H51-C108236443FEB86687F48FC9 - Point of use confirmation required
- true
Source ID
H51-1E5637997526D55648A67405 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-C1BD7BEDF790C872300E1334 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ceftobiprole%20medocaril (opens in a new tab)
Source ID
H51-A705424F4406F6FC4AB195C0
Version updated
5.1Source ID
H51-ECEF3417436F3E7CAC9B60A7Dosing source fields
Id
ceftobiprole-medocarilSource ID
H51-87238436C702589AFCB9083AGeneric name
Ceftobiprole medocarilSource ID
H51-59807C0A2B095F689E88A8C6Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-EFBBB7136CF26EF3B42B41A3Package insert
- Query name
- Ceftobiprole medocaril
Source ID
H51-F9F124E31D1E90E6C2A57156 - Product and route must match
- true
Source ID
H51-E469F9D48D743B17111E55B8 - Live current label enabled
- false
Source ID
H51-438D344122FC59FC6FFCE772 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-A44A07C2807D4219144BE159 - Direct official label access enabled
- true
Source ID
H51-52C23A6BA761CED9E1951499 - Outbound server request required
- false
Source ID
H51-4930F07FBB2EE584C8BFA593 - Local summary status
- not_bundled
Source ID
H51-64CFC648258FCA33656913E4
Clinical review
- Locally normalized
- false
Source ID
H51-1901A197A5482BA1721BF888 - Reviewed
- 2026-08-29
Source ID
H51-25B433D4A0CF6E45B59BA6E1 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-3979DA99CA8EC81E46729BFF
Clinical release verification
- Audit version
- 3.4
Source ID
H51-689D8F1E6057B764DD1F5A6C - Audited on
- 2026-08-30
Source ID
H51-30AAB120C92D5C7237822B0F - Level
- amber
Source ID
H51-9FF882A54BE6D5C02F0D4276 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-4D1797F5B620A3AF5616357B - Exact current label candidate
- false
Source ID
H51-BFD4C0714C101833BC9E08FA - Numeric support ratio
- 0
Source ID
H51-1B367E8C3D5646E11801EF03 - Reference url count
- 5
Source ID
H51-0DE3B40018292949E46BF515 - Broken reference count
- 0
Source ID
H51-97F2AC005EF20C388AFD669F - Point of use confirmation required
- true
Source ID
H51-BE8BAF04DD1CBC6E1D6B2904 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-0443EB7EBF1E252A210421F6 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ceftobiprole%20medocaril (opens in a new tab)
Source ID
H51-E6E069DFE2D5F146C2B466BF
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- ceftobiprole-medocaril
Source ID
H51-C1B79D7676A7224724036EB8 - Name
- Ceftobiprole medocaril
Source ID
H51-7219C56CD1E44F399E01D39A - Brands
- Zevtera
Source ID
H51-70D7B4C2A6AB7567B12182F7 - Therapeutic class
- Antibacterial
Source ID
H51-CDD860856DB749A8AF0EDB8D - Review version
- 3.1
Source ID
H51-03AA8DF822DD2BD8AAD2ACF3 - Review date
- 2026-08-30
Source ID
H51-454FB0724F80F4C4FECEEA9B - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-F7943059BB962EBDFCDB3B91 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-E8137625253B87078CDFF1F1 - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-A6A95D5155C2952AB72D3087
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-07BE6E998DD53139B873A758 - Reconstitution concentration
- Reconstitute vial with the label-specified volume and diluent; gently invert or swirl. Reconstitute per product labeling.
Source ID
H51-B6D2B90290B77D707685B64D - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-F59558B150BB4D21A6DB5097 - Appropriate standardized containers
- Common final bag volume per label and patient fluid needs Weight-appropriate volume
Source ID
H51-7624CB7F21EC15E7A4E3E420 - Adult dosing range
- 667 mg ceftobiprole medocaril per dose for many adult indications Weight- and age-based label dose
Source ID
H51-DCE8587755D1052382F9FF5B - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6C37CAF814F7C33DA0D33ECF - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-658088B64AD708B59687D326 - Infusion time
- Infuse over 2 hours
Source ID
H51-09C600CC6631E015ADB6E281 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-DE94DC42ED3EB862E74275FA - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-99A93C9415A8FBBA8861BE4E - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ceftobiprole+medocaril (opens in a new tab)
Source ID
H51-C0C1B07EE84EE21D97C0CB50
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-4C2A44EEE9DF7F43D8D62CFC
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-DBEF97326AD2131D67F6E5A8
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-09C630979ABDF3A3982DA81E
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-DEDB53E4A1D9526A291A08F9
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-3CD014073461B16F5377391F
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-922890979F9A0AFB01F843CA
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-13636F8480BBD4ED577C0DBB
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-C4B797D53CD74CF0A487B8BA
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-2AA17E877F5C67843E4860B1
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-A4C5DA6CD86EAED7600CE78C
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-282E82AD5F982B81DF5A629E - Guide generation allowed
- true
Source ID
H51-6EE0A4F75497432E5DA3A7B2
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-856D37D91D57600FA9DB9F0C - Guide generation allowed
- false
Source ID
H51-1419143277F019A820A9011A
- Neonatal
- Applicability
- supported_or_source_present
Source ID
H51-0CE8AE282BCBECAB97D3B78F - Guide generation allowed
- false
Source ID
H51-660DD60D4CA6807BBA72343A
- Route presence
- Structured dilution
- true
Source ID
H51-0A61D10C7F8F65CC888A2D12 - Iv push
- false
Source ID
H51-17E5C1DA90C3BD794EF5D0C0 - Continuous infusion
- false
Source ID
H51-1300A31C946612FF23F9E881 - Pediatric source
- true
Source ID
H51-8CC2C77A8D0A5A271C517174 - Neonatal source
- true
Source ID
H51-1AEC987CF1D1CAC8B33D52BC
- Legacy reference
- Status
- not_available
Source ID
H51-31407DD62E8F85245079DEE8
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-7390439155A244FB448004B8
- Source files
- catalog.json
Source ID
H51-703337FC6A388151B8E6F791 - dosing.json
Source ID
H51-BF7B66CB2D8A46BEEE2F1121 - new-in-v1.2.json
Source ID
H51-5F27BECE455D0A58A22347CA
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-61C71832E0EE8F6E3981A981
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-76293988DDA72411660C9A9A | catalog.json/records/54/id | Historical; current review incomplete |
H51-FD326E325D5766A22AA1EC04 | catalog.json/records/54/generic_name | Historical; current review incomplete |
H51-29AF9CBB14B4993B137B53F0 | catalog.json/records/54/brand_names/0 | Historical; current review incomplete |
H51-FB6F8C22BA4CD8334AB9AB76 | catalog.json/records/54/aliases/0 | Historical; current review incomplete |
H51-AB9181AF390758B8828DBEEB | catalog.json/records/54/class | Historical; current review incomplete |
H51-5023B05747EE59F4E1006D4B | catalog.json/records/54/subclass | Historical; current review incomplete |
H51-8E3A43F92D0D666A40010782 | catalog.json/records/54/summary | Historical; current review incomplete |
H51-20B7693A62219DE93E0D97D1 | catalog.json/records/54/common_uses/0 | Historical; current review incomplete |
H51-725EEA20C89B5D403C902167 | catalog.json/records/54/common_uses/1 | Historical; current review incomplete |
H51-E79085E3071A38C94132F126 | catalog.json/records/54/common_uses/2 | Historical; current review incomplete |
H51-F73C5D34E9924BD51626DA08 | catalog.json/records/54/preparations/0 | Historical; current review incomplete |
H51-5C34F05F787E373A2923DC0F | catalog.json/records/54/preparations/0/population | Historical; current review incomplete |
H51-C1B78F5659DAF5C4A9A21AFA | catalog.json/records/54/preparations/0/amount | Historical; current review incomplete |
H51-CA25DEC0F949CD5D9557C3ED | catalog.json/records/54/preparations/0/reconstitution | Historical; current review incomplete |
H51-FFEB414E8FC3527DB98B75F0 | catalog.json/records/54/preparations/0/diluent | Historical; current review incomplete |
H51-2BED59DD26A55638328767BF | catalog.json/records/54/preparations/0/final_volume | Historical; current review incomplete |
H51-7221180C832E7FF74F848596 | catalog.json/records/54/preparations/0/concentration | Historical; current review incomplete |
H51-08DBC80EB5E9DB2BA0FFB5FB | catalog.json/records/54/preparations/0/rate | Historical; current review incomplete |
H51-D35566752517C63CE603DB72 | catalog.json/records/54/preparations/0/stability | Historical; current review incomplete |
H51-EB14A3B18E102EDD165098E1 | catalog.json/records/54/preparations/0/notes | Historical; current review incomplete |
H51-73A72754AEF8545F68DA05ED | catalog.json/records/54/preparations/1 | Historical; current review incomplete |
H51-23CACB7E9F042A42C3D710D3 | catalog.json/records/54/preparations/1/population | Historical; current review incomplete |
H51-1FC52BB40B15DE22120DCBAD | catalog.json/records/54/preparations/1/amount | Historical; current review incomplete |
H51-C8FE1E92C9CDC81BAAD988FB | catalog.json/records/54/preparations/1/reconstitution | Historical; current review incomplete |
H51-835745D4C4568F3D4B04367D | catalog.json/records/54/preparations/1/diluent | Historical; current review incomplete |
H51-F0032F8738F0BCE1EFAF453A | catalog.json/records/54/preparations/1/final_volume | Historical; current review incomplete |
H51-2729AF6583BCAA05EC515BA5 | catalog.json/records/54/preparations/1/concentration | Historical; current review incomplete |
H51-803E737C37192BC0070011E2 | catalog.json/records/54/preparations/1/rate | Historical; current review incomplete |
H51-B1446D19256EF92124AB2C20 | catalog.json/records/54/preparations/1/stability | Historical; current review incomplete |
H51-B8FCD88EADBE8471B2C335B5 | catalog.json/records/54/preparations/1/notes | Historical; current review incomplete |
H51-AC31CF41B01E6A1DD18F9F64 | catalog.json/records/54/warnings/0 | Historical; current review incomplete |
H51-BA4F7526AF6E019E33CBF792 | catalog.json/records/54/warnings/1 | Historical; current review incomplete |
H51-5B09D964D03E47A6DE1662BC | catalog.json/records/54/warnings/2 | Historical; current review incomplete |
H51-DBD05811B7324B0967563D16 | catalog.json/records/54/monitoring/0 | Historical; current review incomplete |
H51-E0625787077650218012248A | catalog.json/records/54/monitoring/1 | Historical; current review incomplete |
H51-E5CB29908CA65DF15B45CFC4 | catalog.json/records/54/monitoring/2 | Historical; current review incomplete |
H51-9D82E2185B8F2DDD0D298047 | catalog.json/records/54/populations/0 | Historical; current review incomplete |
H51-C3893BF4768749DADF9FA76D | catalog.json/records/54/populations/1 | Historical; current review incomplete |
H51-39229D5BF484FA66256B9A1E | catalog.json/records/54/evidence_tier | Historical; current review incomplete |
H51-537F94AEA858DF502FF5FDEE | catalog.json/records/54/high_alert | Historical; current review incomplete |
H51-C7B21AC61A18D0F0F77B5A57 | catalog.json/records/54/hazardous | Historical; current review incomplete |
H51-323D5537B743FC46A9495D64 | catalog.json/records/54/status | Historical; current review incomplete |
H51-E6F1928503277F901A483874 | catalog.json/records/54/reviewed | Historical; current review incomplete |
H51-5241062DBAA7F48716F3A999 | catalog.json/records/54/version_added | Historical; current review incomplete |
H51-911CDE96AFE95E959A4D9E78 | catalog.json/records/54/sources/0 | Historical; current review incomplete |
H51-EC7492E58AD27AE5238116B5 | catalog.json/records/54/sources/0/label | Historical; current review incomplete |
H51-E3ACF4E6C2750BF9B7FC5241 | catalog.json/records/54/sources/0/url | Historical; current review incomplete |
H51-24C949B969653A7974EDBD0D | catalog.json/records/54/sources/0/kind | Historical; current review incomplete |
H51-4DB5315A41595FE7F1572AD1 | catalog.json/records/54/sources/1 | Historical; current review incomplete |
H51-A9D32C1B22BEC88207771F19 | catalog.json/records/54/sources/1/label | Historical; current review incomplete |
H51-36D4629FDAD74227C9CD04F6 | catalog.json/records/54/sources/1/url | Historical; current review incomplete |
H51-53B4A3560A3A2555EEB37CF6 | catalog.json/records/54/sources/1/kind | Historical; current review incomplete |
H51-C0A7244313D106AA8B64034F | catalog.json/records/54/legacy_title | Historical; current review incomplete |
H51-99974F269D0C3F19AFCB9B42 | catalog.json/records/54/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-AD313936CD1E1EAC6D706298 | catalog.json/records/54/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-D5FF272FC05073F2A6B9E25A | catalog.json/records/54/clinical_release_verification/level | Historical; current review incomplete |
H51-D281DBCD09E3EA01ACA46732 | catalog.json/records/54/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-3F59BB5A5B4A6E166576D619 | catalog.json/records/54/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-CAB878726DF1C855B312C5A1 | catalog.json/records/54/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-7BB275A8D8EF2E54B35F3EA4 | catalog.json/records/54/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-0C5C1711A4B6A7EDE6FED90E | catalog.json/records/54/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-DE4D7C5DE0E6ABDB849C0049 | catalog.json/records/54/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-C108236443FEB86687F48FC9 | catalog.json/records/54/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-1E5637997526D55648A67405 | catalog.json/records/54/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-C1BD7BEDF790C872300E1334 | catalog.json/records/54/clinical_release_verification/note | Historical; current review incomplete |
H51-A705424F4406F6FC4AB195C0 | catalog.json/records/54/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-ECEF3417436F3E7CAC9B60A7 | catalog.json/records/54/version_updated | Historical; current review incomplete |
H51-5F85653B4E257A1B2DD27720 | dailymed-label-snapshots-v5.1.json/records/17/id | Historical; current review incomplete |
H51-6ED3D9FEC913DE760F93F0D0 | dailymed-label-snapshots-v5.1.json/records/17/catalog_name | Historical; current review incomplete |
H51-BD6C7E4FC650D044829B3396 | dailymed-label-snapshots-v5.1.json/records/17/selection_status | Historical; current review incomplete |
H51-DE55FBF3EA552B081F099EBF | dailymed-label-snapshots-v5.1.json/records/17/confidence | Historical; current review incomplete |
H51-792856CC211DA2931D646534 | dailymed-label-snapshots-v5.1.json/records/17/match_path | Historical; current review incomplete |
H51-134BEB7B9F5AC6B5587957C0 | dailymed-label-snapshots-v5.1.json/records/17/brand_name | Historical; current review incomplete |
H51-6C6355582CB3F35B9977886B | dailymed-label-snapshots-v5.1.json/records/17/label_title | Historical; current review incomplete |
H51-6C73000E7739A3EEFA932BAF | dailymed-label-snapshots-v5.1.json/records/17/setid | Historical; current review incomplete |
H51-C775A84381F91BB79CAF7A45 | dailymed-label-snapshots-v5.1.json/records/17/route | Historical; current review incomplete |
H51-90498D46C92B15D6E43254AF | dailymed-label-snapshots-v5.1.json/records/17/dosage_form | Historical; current review incomplete |
H51-50AC60D30C494E5BEA142676 | dailymed-label-snapshots-v5.1.json/records/17/dosage_administration_summary/0 | Historical; current review incomplete |
H51-5C36A9C692AD503309A030B3 | dailymed-label-snapshots-v5.1.json/records/17/dosage_administration_summary/1 | Historical; current review incomplete |
H51-25151CE223B085D58FF4F143 | dailymed-label-snapshots-v5.1.json/records/17/dosage_administration_summary/2 | Historical; current review incomplete |
H51-5653D5E7025DDD368CF0979B | dailymed-label-snapshots-v5.1.json/records/17/dosage_forms_strengths/0 | Historical; current review incomplete |
H51-9F17060546A999E999EBF5D2 | dailymed-label-snapshots-v5.1.json/records/17/mechanism_summary | Historical; current review incomplete |
H51-E73199DA956ED8901516C589 | dailymed-label-snapshots-v5.1.json/records/17/scope_note | Historical; current review incomplete |
H51-039E385FEC1876A0AD40BC11 | dailymed-label-snapshots-v5.1.json/records/17/labeler | Historical; current review incomplete |
H51-4FB7AD480219C639ACD931FC | dailymed-label-snapshots-v5.1.json/records/17/official_label_url | Historical; current review incomplete |
H51-037097B45B9C1D9783DA947B | dailymed-label-snapshots-v5.1.json/records/17/reviewed_on | Historical; current review incomplete |
H51-AB0F69B1C9128768C88DB70F | dailymed-label-snapshots-v5.1.json/records/17/mechanism_source | Historical; current review incomplete |
H51-2B34588C77F41588D48F6590 | dailymed-label-snapshots-v5.1.json/records/17/source_sections/0 | Historical; current review incomplete |
H51-E60134564B2C11C87B0FE630 | dailymed-label-snapshots-v5.1.json/records/17/source_sections/1 | Historical; current review incomplete |
H51-68F74BD79057961CC070AF51 | dailymed-label-snapshots-v5.1.json/records/17/source_sections/2 | Historical; current review incomplete |
H51-15317FC5AE29E04D79838BC1 | dailymed-label-snapshots-v5.1.json/records/17/retrieval_method | Historical; current review incomplete |
H51-4F32BCCBDD563B086668481C | dailymed-label-snapshots-v5.1.json/records/17/label_status | Historical; current review incomplete |
H51-11C7F31A1BD1345466F4D333 | dailymed-label-snapshots-v5.1.json/records/17/disclaimer | Historical; current review incomplete |
H51-87238436C702589AFCB9083A | dosing.json/records/54/id | Historical; current review incomplete |
H51-59807C0A2B095F689E88A8C6 | dosing.json/records/54/generic_name | Historical; current review incomplete |
H51-EFBBB7136CF26EF3B42B41A3 | dosing.json/records/54/coverage_status | Historical; current review incomplete |
H51-F9F124E31D1E90E6C2A57156 | dosing.json/records/54/package_insert/query_name | Historical; current review incomplete |
H51-97FFC384510625E9E408469D | dosing.json/records/54/package_insert/preferred_setid | Historical; current review incomplete |
H51-E469F9D48D743B17111E55B8 | dosing.json/records/54/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-438D344122FC59FC6FFCE772 | dosing.json/records/54/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-A44A07C2807D4219144BE159 | dosing.json/records/54/package_insert/source_priority | Historical; current review incomplete |
H51-52C23A6BA761CED9E1951499 | dosing.json/records/54/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-4930F07FBB2EE584C8BFA593 | dosing.json/records/54/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-64CFC648258FCA33656913E4 | dosing.json/records/54/package_insert/local_summary_status | Historical; current review incomplete |
H51-D5C3D0402385F443294C79D9 | dosing.json/records/54/renal/classification | Historical; current review incomplete |
H51-6B3DE17D1900BC826036077E | dosing.json/records/54/renal/summary | Historical; current review incomplete |
H51-17D32C85A9D16FB728E41AF9 | dosing.json/records/54/renal/method_note | Historical; current review incomplete |
H51-4741CC01B0633CFD9811C258 | dosing.json/records/54/existing_route_snapshots/0 | Historical; current review incomplete |
H51-543E5557B927C3D8ED2CB1E5 | dosing.json/records/54/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-8C50BB29EFFF2BCF632AAB45 | dosing.json/records/54/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-49AFB510C07A2717538E97B8 | dosing.json/records/54/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-30EE129B97ABA875969059A9 | dosing.json/records/54/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-2F9047706CACF24DAB7F3C76 | dosing.json/records/54/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-33F319025E9B021988662454 | dosing.json/records/54/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-10AA0C33BEE187641CC2FF7A | dosing.json/records/54/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-B2097418E1265B7E8F54D1A1 | dosing.json/records/54/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-66BC338F4F9CABAA94B49167 | dosing.json/records/54/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-E360FFB8018AD16808ACEBF8 | dosing.json/records/54/existing_route_snapshots/1 | Historical; current review incomplete |
H51-CB7A8776594B700557F690D0 | dosing.json/records/54/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-14981E78EC164497A0851A68 | dosing.json/records/54/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-E1CD2B86514FA39DD7CD9BB9 | dosing.json/records/54/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-8E1B50425B8D3365C7FFADC8 | dosing.json/records/54/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-8C74CD2DDE7722C05CDBC6A5 | dosing.json/records/54/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-F1F3E1A25595A2888F6305F0 | dosing.json/records/54/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-71E28BF8CF41B155375A16B4 | dosing.json/records/54/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-C875FC97D9BA462116A30019 | dosing.json/records/54/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-CACAE5C7ACA339A9C239F6BD | dosing.json/records/54/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-1B5FA04CE2DE068DC9604476 | dosing.json/records/54/professional_sources/0 | Historical; current review incomplete |
H51-84F5A65F07379C3187F002D1 | dosing.json/records/54/professional_sources/0/label | Historical; current review incomplete |
H51-DFCA8974405CBE8255FD48E0 | dosing.json/records/54/professional_sources/0/url | Historical; current review incomplete |
H51-A3FFB9B3CB82CB314E9CDB49 | dosing.json/records/54/professional_sources/0/kind | Historical; current review incomplete |
H51-E25D134A9E120D4B740D7ECA | dosing.json/records/54/professional_sources/1 | Historical; current review incomplete |
H51-DDEA728E01EDD38C6446CF0F | dosing.json/records/54/professional_sources/1/label | Historical; current review incomplete |
H51-FF4F6437D8BB65D364652563 | dosing.json/records/54/professional_sources/1/url | Historical; current review incomplete |
H51-5352DC9DB5413A53DD73D7BE | dosing.json/records/54/professional_sources/1/kind | Historical; current review incomplete |
H51-EB1EC3F8D2146C0035E1B3D6 | dosing.json/records/54/professional_sources/2 | Historical; current review incomplete |
H51-6007B6A793378888E5DD341D | dosing.json/records/54/professional_sources/2/label | Historical; current review incomplete |
H51-1DDE28E93202ED95C7972583 | dosing.json/records/54/professional_sources/2/url | Historical; current review incomplete |
H51-45FAD15AB4723E4EE011A1CF | dosing.json/records/54/professional_sources/2/kind | Historical; current review incomplete |
H51-31E8901664B4A1885B44B962 | dosing.json/records/54/professional_sources/3 | Historical; current review incomplete |
H51-40E51E0E2995B679B7C8AD21 | dosing.json/records/54/professional_sources/3/label | Historical; current review incomplete |
H51-C4FC0D20E8CB32D162767E55 | dosing.json/records/54/professional_sources/3/url | Historical; current review incomplete |
H51-1F3D87B9464837157180DA4F | dosing.json/records/54/professional_sources/3/kind | Historical; current review incomplete |
H51-1901A197A5482BA1721BF888 | dosing.json/records/54/clinical_review/locally_normalized | Historical; current review incomplete |
H51-25B433D4A0CF6E45B59BA6E1 | dosing.json/records/54/clinical_review/reviewed | Historical; current review incomplete |
H51-3979DA99CA8EC81E46729BFF | dosing.json/records/54/clinical_review/status | Historical; current review incomplete |
H51-689D8F1E6057B764DD1F5A6C | dosing.json/records/54/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-30AAB120C92D5C7237822B0F | dosing.json/records/54/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-9FF882A54BE6D5C02F0D4276 | dosing.json/records/54/clinical_release_verification/level | Historical; current review incomplete |
H51-4D1797F5B620A3AF5616357B | dosing.json/records/54/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-BFD4C0714C101833BC9E08FA | dosing.json/records/54/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-3B08DCA27146826F670E441D | dosing.json/records/54/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-D876F4133C20A81056409FB9 | dosing.json/records/54/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-1B367E8C3D5646E11801EF03 | dosing.json/records/54/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-0DE3B40018292949E46BF515 | dosing.json/records/54/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-97F2AC005EF20C388AFD669F | dosing.json/records/54/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-BE8BAF04DD1CBC6E1D6B2904 | dosing.json/records/54/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-0443EB7EBF1E252A210421F6 | dosing.json/records/54/clinical_release_verification/note | Historical; current review incomplete |
H51-E6E069DFE2D5F146C2B466BF | dosing.json/records/54/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-01F3C0CF05FEBBB206C01911 | first-look-v5.1.json/records/54/id | Historical; current review incomplete |
H51-0057A8DAE863AAF3AFDC0443 | first-look-v5.1.json/records/54/generic_name | Historical; current review incomplete |
H51-75F42E7A7A2A16C90CC66E23 | first-look-v5.1.json/records/54/class | Historical; current review incomplete |
H51-3795026EC17BF85F30A5B7B2 | first-look-v5.1.json/records/54/subclass | Historical; current review incomplete |
H51-261E585A2C8950F1F66F6183 | first-look-v5.1.json/records/54/primary_uses/0 | Historical; current review incomplete |
H51-A16609A67673B058A6184383 | first-look-v5.1.json/records/54/primary_uses/1 | Historical; current review incomplete |
H51-0201A5EA91D546DA1CBB8596 | first-look-v5.1.json/records/54/primary_uses/2 | Historical; current review incomplete |
H51-1DA2686D2082C88A0A374799 | first-look-v5.1.json/records/54/mechanism | Historical; current review incomplete |
H51-166CA2A06AC88568F51FB47C | first-look-v5.1.json/records/54/mechanism_level | Historical; current review incomplete |
H51-EB2E2A4B3F2E1E1769AD6D83 | first-look-v5.1.json/records/54/basic_dosing_orientation | Historical; current review incomplete |
H51-4499BE0F5C6D4887891FFC4E | first-look-v5.1.json/records/54/administration_orientation | Historical; current review incomplete |
H51-DA9604825D7A44B5E57A4D0F | first-look-v5.1.json/records/54/renal_and_population_orientation | Historical; current review incomplete |
H51-5BD6453F3C05DF03ACDAC747 | first-look-v5.1.json/records/54/key_safety_orientation/0 | Historical; current review incomplete |
H51-A35B2167C83F48051D82B1C8 | first-look-v5.1.json/records/54/key_safety_orientation/1 | Historical; current review incomplete |
H51-D39B14C24B719E18A3631CB2 | first-look-v5.1.json/records/54/key_safety_orientation/2 | Historical; current review incomplete |
H51-DC66FE5A1091EC722C5870B0 | first-look-v5.1.json/records/54/coverage_path | Historical; current review incomplete |
H51-F22F18375BB7F964008918C1 | first-look-v5.1.json/records/54/coverage_path_label | Historical; current review incomplete |
H51-5A9E47AEB294FF0BD7CEFCCC | first-look-v5.1.json/records/54/official_label_url | Historical; current review incomplete |
H51-D9F4CBCCEC97A671DC4A6E41 | first-look-v5.1.json/records/54/legacy_title | Historical; current review incomplete |
H51-AE006DA622F0CAE94C011889 | first-look-v5.1.json/records/54/review_note | Historical; current review incomplete |
H51-2880EF1358E4F08C5E2EB38A | first-look-v5.1.json/records/54/search_text | Historical; current review incomplete |
H51-47D9FFD5F4C64766EE4C6790 | first-look-v5.1.json/records/54/official_search_url | Historical; current review incomplete |
H51-C578B421178F56700A58DFEA | first-look-v5.1.json/records/54/official_access_mode | Historical; current review incomplete |
H51-B09197A7AAA909628A09431A | first-look-v5.1.json/records/54/official_access_url | Historical; current review incomplete |
H51-DC2DC674535736508C13B1E9 | first-look-v5.1.json/records/54/official_search_query | Historical; current review incomplete |
H51-F2D6312CF1B3FC85B493ABBB | first-look-v5.1.json/records/54/official_access_reason | Historical; current review incomplete |
H51-DEACE64129625B5D6C83C520 | first-look-v5.1.json/records/54/label_snapshot_available | Historical; current review incomplete |
H51-08B7848A6E2AA9454615DAE5 | first-look-v5.1.json/records/54/label_snapshot_setid | Historical; current review incomplete |
H51-C1B79D7676A7224724036EB8 | preparation-assessments-v3.8.json/54/id | Historical; current review incomplete |
H51-7219C56CD1E44F399E01D39A | preparation-assessments-v3.8.json/54/name | Historical; current review incomplete |
H51-70D7B4C2A6AB7567B12182F7 | preparation-assessments-v3.8.json/54/brands | Historical; current review incomplete |
H51-CDD860856DB749A8AF0EDB8D | preparation-assessments-v3.8.json/54/therapeutic_class | Historical; current review incomplete |
H51-03AA8DF822DD2BD8AAD2ACF3 | preparation-assessments-v3.8.json/54/review_version | Historical; current review incomplete |
H51-454FB0724F80F4C4FECEEA9B | preparation-assessments-v3.8.json/54/review_date | Historical; current review incomplete |
H51-F7943059BB962EBDFCDB3B91 | preparation-assessments-v3.8.json/54/release_status | Historical; current review incomplete |
H51-E8137625253B87078CDFF1F1 | preparation-assessments-v3.8.json/54/market_status/status | Historical; current review incomplete |
H51-A6A95D5155C2952AB72D3087 | preparation-assessments-v3.8.json/54/market_status/basis | Historical; current review incomplete |
H51-07BE6E998DD53139B873A758 | preparation-assessments-v3.8.json/54/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-B6D2B90290B77D707685B64D | preparation-assessments-v3.8.json/54/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-F59558B150BB4D21A6DB5097 | preparation-assessments-v3.8.json/54/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-7624CB7F21EC15E7A4E3E420 | preparation-assessments-v3.8.json/54/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-DCE8587755D1052382F9FF5B | preparation-assessments-v3.8.json/54/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-6C37CAF814F7C33DA0D33ECF | preparation-assessments-v3.8.json/54/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-658088B64AD708B59687D326 | preparation-assessments-v3.8.json/54/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-09C600CC6631E015ADB6E281 | preparation-assessments-v3.8.json/54/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-DE94DC42ED3EB862E74275FA | preparation-assessments-v3.8.json/54/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-711E502225250095A106AE80 | preparation-assessments-v3.8.json/54/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-607D2E1F8D7CE7478BA3B95A | preparation-assessments-v3.8.json/54/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-60B03898DC44C79942D0ADCD | preparation-assessments-v3.8.json/54/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-FF199B430292119605FE794E | preparation-assessments-v3.8.json/54/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-99A93C9415A8FBBA8861BE4E | preparation-assessments-v3.8.json/54/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-C0C1B07EE84EE21D97C0CB50 | preparation-assessments-v3.8.json/54/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-4C2A44EEE9DF7F43D8D62CFC | preparation-assessments-v3.8.json/54/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-DBEF97326AD2131D67F6E5A8 | preparation-assessments-v3.8.json/54/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-09C630979ABDF3A3982DA81E | preparation-assessments-v3.8.json/54/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-DEDB53E4A1D9526A291A08F9 | preparation-assessments-v3.8.json/54/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-3CD014073461B16F5377391F | preparation-assessments-v3.8.json/54/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-922890979F9A0AFB01F843CA | preparation-assessments-v3.8.json/54/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-13636F8480BBD4ED577C0DBB | preparation-assessments-v3.8.json/54/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-C4B797D53CD74CF0A487B8BA | preparation-assessments-v3.8.json/54/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-2AA17E877F5C67843E4860B1 | preparation-assessments-v3.8.json/54/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-A4C5DA6CD86EAED7600CE78C | preparation-assessments-v3.8.json/54/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-282E82AD5F982B81DF5A629E | preparation-assessments-v3.8.json/54/population_applicability/adult/applicability | Historical; current review incomplete |
H51-6EE0A4F75497432E5DA3A7B2 | preparation-assessments-v3.8.json/54/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-856D37D91D57600FA9DB9F0C | preparation-assessments-v3.8.json/54/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-1419143277F019A820A9011A | preparation-assessments-v3.8.json/54/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-0CE8AE282BCBECAB97D3B78F | preparation-assessments-v3.8.json/54/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-660DD60D4CA6807BBA72343A | preparation-assessments-v3.8.json/54/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-0A61D10C7F8F65CC888A2D12 | preparation-assessments-v3.8.json/54/route_presence/structured_dilution | Historical; current review incomplete |
H51-17E5C1DA90C3BD794EF5D0C0 | preparation-assessments-v3.8.json/54/route_presence/iv_push | Historical; current review incomplete |
H51-1300A31C946612FF23F9E881 | preparation-assessments-v3.8.json/54/route_presence/continuous_infusion | Historical; current review incomplete |
H51-8CC2C77A8D0A5A271C517174 | preparation-assessments-v3.8.json/54/route_presence/pediatric_source | Historical; current review incomplete |
H51-1AEC987CF1D1CAC8B33D52BC | preparation-assessments-v3.8.json/54/route_presence/neonatal_source | Historical; current review incomplete |
H51-31407DD62E8F85245079DEE8 | preparation-assessments-v3.8.json/54/legacy_reference/status | Historical; current review incomplete |
H51-7390439155A244FB448004B8 | preparation-assessments-v3.8.json/54/label_resolution/status | Historical; current review incomplete |
H51-703337FC6A388151B8E6F791 | preparation-assessments-v3.8.json/54/source_files/0 | Historical; current review incomplete |
H51-BF7B66CB2D8A46BEEE2F1121 | preparation-assessments-v3.8.json/54/source_files/1 | Historical; current review incomplete |
H51-5F27BECE455D0A58A22347CA | preparation-assessments-v3.8.json/54/source_files/2 | Historical; current review incomplete |
H51-61C71832E0EE8F6E3981A981 | preparation-assessments-v3.8.json/54/clinical_release_note | Historical; current review incomplete |